Infection in Pulmonary Vascular Disease (iPVD) Consortium

The Infection in Pulmonary Vascular Disease (iPVD) Consortium’s primary focus is to enhance awareness about the role of infection on PVD, and foster research collaborations in infectious diseases covering basic science, translational and clinical aspects, aiming to better understand its mechanisms and global impact.

Find out more about the iPVD Consortium

iPVD Virtual Symposium Webinar Series

The iPVD Consortium Virtual Symposium webinar series, hosted by PVRI, is a global education programme highlighting the latest research on infections in PVD. The webinars provide a great opportunity for international speakers to participate, present, and ask questions of our fantastic committee. Webinars are held on the last Wednesday of the month at 15:00 BST/GMT, and recordings are available on our website.  

The Microbes webinar series

• Microbes/Parasites and Sex Differences in PVDs, 26 November 2025
• Co-Infection and Pulmonary Vascular Disease, November 2024
• Clinical Aspects, August 2024
• Bacteria, May 2024
• Microbiome and microbial metabolites, March 2024.

Other webinars

• Pulmonary Hypertension in the Shadow of Infections: Challenges in Indian Practice, August 2025
• Perspectives on global epidemiology challenges, February 2025

Events

iPVD Annual Symposia

Annual iPVD Consortium meetings are usually held as a pre-conference session at PVRI Conferences. The meetings bring together researchers and clinicians worldwide to share their latest findings on the pathogenesis, diagnosis, and treatment of infectious PVDs. They cover a wide range of topics, including:

• the epidemiology and risk factors for infectious PVDs
• the molecular mechanisms by which infections trigger and worsen PVD
• new diagnostic tools and biomarkers for infectious PVDs

• emerging therapeutic strategies for infectious PVDs

   

5th iPVD Symposium held at PVRI 2026 Dublin

The programme examined challenges in clinical trials, environmental stressors affecting the pulmonary vasculature, and new insights into the microbiome's role in PVD. 

 Watch the recordings here

Publications 

• Oliveira, S.D., Almodóvar, S., Butrous, G., De Jesus Perez, V., Fabro, A. et al. (2024) ‘Infection and pulmonary vascular diseases consortium: United against a global health challenge’. Pulmonary Circulation, 14(4), e70003
• Kumar, R., Aktay-Cetin, Ö., Craddock, V., Morales-Cano, D., Kosanovic, D. et al. (2023) ‘Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities’. PLOS Pathogens, 19(1), e1011063
• Oliveira, R.K.F., Nyasulu, P.S., Iqbal, A.A., Gul, M.H., Ferreira, E.V.M. et al. (2022) ‘Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges’. Frontiers in Medicine, 9, 1041236
• Halawa, S., Pullamsetti, S.S., Bangham, C.R.M., Stenmark, K.R., Dorfmüller, P. et al. (2022) ‘Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: A global perspective’. Nature Reviews Cardiology, 19, 314–331

If you are interested in joining this Task Force, please fill in the form below.
iPVD Member Contact Information Form